A novel modular bioreactor to in Vitro study the hepatic sinusoid

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Illa, Xavi ^a,b   Vila, Sergi ^c   Yeste, Jose ^a,b   Peralta, Carmen ^d   Gracia Sancho, Jordi ^c   Villa, Rosa ^a,b  

^a INSTITUTO DE MICROELECTRÓNICA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOREACTOR; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER SINUSOID; PARACRINE SIGNALING; PHENOTYPE; STELLATE CELL; CYTOLOGY; DEVICES; MECHANICAL STRESS; METABOLISM; PROCEDURES; UMBILICAL VEIN;

BIOREACTORS; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HEPATIC STELLATE CELLS; HUMANS; STRESS, MECHANICAL; UMBILICAL VEINS;

EID: 84910650521     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111864     Document Type: Article

References (45)

1. Kim L, Toh Y-C, Voldman J, Yu H (2007) A practical guide to microfluidic perfusion culture of adherent mammalian cells. Lab Chip 7: 681-694. doi: 10.1039/B704602B.
2. Morimoto Y, Takeuchi S (2013) Three-dimensional cell culture based on microfluidic techniques to mimic living tissues. Biomater Sci 1: 257-264. doi: 10.1039/C2BM00117A.
3. Inamdar NK, Borenstein JT (2011) Microfluidic cell culture models for tissue engineering. Curr Opin Biotechnol 22: 681-689. doi: 10.1016/j.copbio.2011.05.512.
4. Baker M (2011) Tissue models: A living system on a chip. Nature 471: 661-665. doi: 10.1038/471661a.
5. Huh D, Hamilton GA, Ingber DE (2011) From 3D cell culture to organs-on-chips. Trends Cell Biol 21: 745-754. doi: 10.1016/j.tcb.2011.09.005.
6. Meer AD van der, Berg A van den (2012) Organs-on-chips: breaking the in vitro impasse. Integr Biol 4: 461-470. doi: 10.1039/C2IB00176D.
7. Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A (2012) Biomimetic tissues on a chip for drug discovery. Drug Discov Today 17: 173-181. doi: 10.1016/j.drudis.2011.10.029.
8. Stolpe A van de, Toonder J den (2013) Workshop meeting report Organs-on-Chips: human disease models. Lab Chip 13: 3449-3470. doi: 10.1039/C3LC50248A.
9. Yum K, Hong SG, Healy KE, Lee LP (2014) Physiologically relevant organs on chips. Biotechnol J 9: 16-27. doi: 10.1002/biot.201300187.
10. Capulli AK, Tian K, Mehandru N, Bukhta A, Choudhury SF, et al. (2014) Approaching the in vitro clinical trial: engineering organs on chips. Lab Chip. Available: http://pubs.rsc.org/en/content/articlelanding/2014/1c/c41c00276h. Accessed 15 May 2014.
11. Polini A, Prodanov L, Bhise NS, Manoharan V, Dokmeci MR, et al. (2014) Organs-on-a-chip: a new tool for drug discovery. Expert Opin Drug Discov 9: 335-352. doi: 10.1517/17460441.2014.886562.
12. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, et al. (2010) Reconstituting Organ-Level Lung Functions on a Chip. Science 328: 1662-1668. doi: 10.1126/science.1188302.
13. Materne E-M, Tonevitsky AG, Marx U (2013) Chip-based liver equivalents for toxicity testing - organotypicalness versus cost-efficient high throughput. Lab Chip 13: 3481-3495. doi: 10.1039/c31c50240f.
14. Kim HJ, Huh D, Hamilton G, Ingber DE (2012) Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12: 2165-2174. doi: 10.1039/C2LC40074J.
15. Jang K-J, Suh K-Y (2010) A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 10: 36-42. doi: 10.1039/b907515a.
16. Ebrahimkhani MR, Neiman JAS, Raredon MSB, Hughes DJ, Griffith LG (2014) Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev 69-70: 132-157. doi: 10.1016/j.addr.2014.02.011.
17. García-Pagán J-C, Gracia-Sancho J, Bosch J (2012) Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol 57: 458-461. doi: 10.1016/j.jhep.2012.03.007.
18. LeCluyse EL, Bullock PL, Parkinson A (1996) Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes. Adv Drug Deliv Rev 22: 133-186. doi: 10.1016/S0169409X(96)00418-8.
19. Powers MJ, Domansky K, Kaazempur-Mofrad MR, Kalezi A, Capitano A, et al. (2002) A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 78: 257-269. doi: 10.1002/bit.10143.
20. Sung JH, Shuler ML (2009) A micro cell culture analog (μCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 9: 1385-1394. doi: 10.1039/B901377F.
21. Carraro A, Hsu W-M, Kulig KM, Cheung WS, Miller ML, et al. (2008) In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed Microdevices 10: 795-805. doi: 10.1007/s10544-008-9194-3.
22. Park J, Berthiaume F, Toner M, Yarmush ML, Tilles AW (2005) Microfabricated grooved substrates as platforms for bioartificial liver reactors. Biotechnol Bioeng 90: 632-644. doi: 10.1002/bit.20463.
23. Lee PJ, Hung PJ, Lee LP (2007) An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng 97: 1340-1346. doi: 10.1002/bit.21360.
24. Zhang MY, Lee PJ, Hung PJ, Johnson T, Lee LP, et al. (2008) Microfluidic environment for high density hepatocyte culture. Biomed Microdevices 10: 117-121. doi: 10.1007/s10544-007-9116-9.
25. Goral VN, Hsieh Y-C, Petzold ON, Clark JS, Yuen PK, et al. (2010) Perfusion-based microfluidic device for three-dimensional dynamic primary human hepatocyte cell culture in the absence of biological or synthetic matrices or coagulants. Lab Chip 10: 3380-3386. doi: 10.1039/C0LC00135J.
26. Meissner R, Eker B, Kasi H, Bertsch A, Renaud P (2011) Distinguishing drug-induced minor morphological changes from major cellular damage via label-free impedimetric toxicity screening. Lab Chip 11: 2352-2361. doi: 10.1039/C1LC20212J.
27. Domansky K, Inman W, Serdy J, Dash A, Lim MHM, et al. (2010) Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 10: 51-58. doi: 10.1039/B913221J.
28. Van Midwoud PM, Groothuis GMM, Merema MT, Verpoorte E (2010) Microfluidic biochip for the perifusion of precision-cut rat liver slices for metabolism and toxicology studies. Biotechnol Bioeng 105: 184-194. doi: 10.1002/bit.22516.
29. Epshteyn AA, Maher S, Taylor AJ, Holton AB, Borenstein JT, et al. (2011) Membrane-integrated microfluidic device for high-resolution live cell imaging. Biomicrofluidics 5: 046501. doi: 10.1063/1.3647824.
30. Griep LM, Wolbers F, Wagenaar B de, Braak PM ter, Weksler BB, et al. (2013) BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 15: 145-150. doi: 10.1007/s10544-012-9699-7.
31. Booth R, Kim H (2012) Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip 12: 1784-1792. doi: 10.1039/C2LC40094D.
32. Kang YB, Sodunke TR, Cirillo J, Bouchard MJ, Noh H (2013) Liver on a chip: Engineering the liver sinusoid. 2013 Transducers Eurosensors XXVII: The 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS EUROSENSORS XXVII). pp. 301-304. doi: 10.1109/Transducers.2013.6626762.
33. Brown TD (2000) Techniques for mechanical stimulation of cells in vitro: a review. J Biomech 33: 3-14. doi: 10.1016/S0021-9290(99)00177-3.
34. Gemmiti CV, Guldberg RE (2006) Fluid Flow Increases Type II Collagen Deposition and Tensile Mechanical Properties in Bioreactor-Grown Tissue-Engineered Cartilage. Tissue Eng 12: 469-479. doi: 10.1089/ten.2006.12.469.
35. Chu PK, Chen JY, Wang LP, Huang N (2002) Plasma-surface modification of biomaterials. Mater Sci Eng R Rep 36: 143-206. doi: 10.1016/S0927796X(02)00004-9.
36. Gracia-Sancho J, Villarreal G, Zhang Y, Yu JX, Liu Y, et al. (2010) Flow Cessation Triggers Endothelial Dysfunction During Organ Cold Storage Conditions: Strategies for Pharmacologic Intervention: Transplant J 90: 142-149. doi: 10.1097/TP.0b013e3181e228db.
37. Marrone G, Russo L, Rosado E, Hide D, García-Cardeña G, et al. (2013) The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. J Hepatol 58: 98-103. doi: 10.1016/j.jhep.2012.08.026.
38. Bacabac RG, Smit TH, Cowin SC, Van Loon JJWA, Nieuwstadt FTM, et al. (2005) Dynamic shear stress in parallel-plate flow chambers. J Biomech 38: 159-167. doi: 10.1016/j.jbiomech.2004.03.020.
39. Kabirian F, Amoabediny G, Haghighipour N, Salehi-Nik N, Zandieh-Doulabi B (2014) Nitric oxide secretion by endothelial cells in response to fluid shear stress, aspirin, and temperature. J Biomed Mater Res A: n/a-n/a. doi: 10.1002/jbm.a.35233.
40. Vion A-C, Ramkhelawon B, Loyer X, Chironi G, Devue C, et al. (2013) Shear Stress Regulates Endothelial Microparticle Release. Circ Res 112: 1323-1333. doi: 10.1161/CIRCRESAHA.112.300818.
41. Vozzi F, Bianchi F, Ahluwalia A, Domenici C (2014) Hydrostatic pressure and shear stress affect endothelin-1 and nitric oxide release by endothelial cells in bioreactors. Biotechnol J 9: 146-154. doi: 10.1002/biot.201300016.
42. Gracia-Sancho J, Laviña B, Rodríguez-Vilarrupla A, García-Calderó H, Fernández M, et al. (2008) Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology 47: 1248-1256. doi: 10.1002/hep.22166.
43. Rosado E, Rodríguez-Vilarrupla A, Gracia-Sancho J, Monclús M, Bosch J, et al. (2012) Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats. J Cell Mol Med 16: 2461-2470. doi: 10.1111/j.1582-4934.2012.01563.x.
44. Hide D, Ortega-Ribera M, Fernandez-Iglesias A, Fondevila C, Salvado MJ, et al. (2014) A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischemia and reperfusion injuries. Clin Sci Lond Engl 1979. doi: 10.1042/CS20140125.
45. Hennenberg M, Trebicka J, Kohistani Z, Stark C, Nischalke H-D, et al. (2011) Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis. Lab Invest 91: 241-251. doi: 10.1038/labinvest.2010.148.